Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1807174
Name of medicinal product: Nobivac Myxo-RHD PLUS
Active substances:
Myxomatosis virus vaccine, live+Rabbit haemorrhagic disease virus, live
Estonian, English, Latin
ATC code: QI08AD80
Dosage form: lyophilisate and solvent for suspension for injection
Route of administration: subcutaneous use
Amount in package: 0.5ml 25TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: For active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and rabbit haemorrhagic disease (RHD) caused by classical RHD virus (RHDV1) and RHD type 2 virus (RHDV2). Onset of immunity: 3 weeks. Duration of immunity: 1 year.
Safety features: No
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Withdrawal time:  
Species: küülik
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Intervet International B.V. 
Marketing authorization number: EU/2/19/244 
Marketing authorization issued on: November 19, 2019 
Marketing authorization expires on: November 21, 2024 
Marketing authorization procedure type: Centralised 
Entry/Changing date: December 2, 2019
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere